John E. Byfield

1.8k total citations
58 papers, 1.4k citations indexed

About

John E. Byfield is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, John E. Byfield has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Oncology and 11 papers in Surgery. Recurrent topics in John E. Byfield's work include DNA Repair Mechanisms (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer therapeutics and mechanisms (7 papers). John E. Byfield is often cited by papers focused on DNA Repair Mechanisms (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer therapeutics and mechanisms (7 papers). John E. Byfield collaborates with scholars based in United States. John E. Byfield's co-authors include Paula M. Calabro-Jones, Otto H. Scherbaum, Ivana Klisak, Young C. Lee, John F. Ward, Sallie S. Frankel, Thomas R. Sharp, Paul Y. M. Chan, Robert M. Barone and Leslie R. Bennett and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

John E. Byfield

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Byfield United States 18 602 527 362 312 136 58 1.4k
Robert E. Wittes United States 21 922 1.5× 618 1.2× 468 1.3× 379 1.2× 81 0.6× 42 2.0k
Paula M. Calabro-Jones United States 12 449 0.7× 435 0.8× 260 0.7× 337 1.1× 243 1.8× 14 1.3k
Aldo Becciolini Italy 19 365 0.6× 402 0.8× 135 0.4× 219 0.7× 279 2.1× 87 1.2k
David P. Houchens United States 21 692 1.1× 485 0.9× 274 0.8× 331 1.1× 222 1.6× 41 1.8k
H Nishikawa Japan 15 718 1.2× 209 0.4× 243 0.7× 1.2k 3.9× 71 0.5× 43 1.9k
F. Mauro Italy 22 323 0.5× 388 0.7× 149 0.4× 299 1.0× 421 3.1× 68 1.4k
B. Tribukait Sweden 20 477 0.8× 841 1.6× 352 1.0× 239 0.8× 351 2.6× 88 1.8k
Tim Underwood United Kingdom 24 675 1.1× 418 0.8× 718 2.0× 543 1.7× 256 1.9× 92 2.0k
Tatsuo Nakagawa Japan 21 408 0.7× 442 0.8× 249 0.7× 594 1.9× 90 0.7× 92 1.5k

Countries citing papers authored by John E. Byfield

Since Specialization
Citations

This map shows the geographic impact of John E. Byfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Byfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Byfield more than expected).

Fields of papers citing papers by John E. Byfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Byfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Byfield. The network helps show where John E. Byfield may publish in the future.

Co-authorship network of co-authors of John E. Byfield

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Byfield. A scholar is included among the top collaborators of John E. Byfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Byfield. John E. Byfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byfield, John E.. (1989). 5-Fluorouracil radiation sensitization — A brief review. Investigational New Drugs. 7(1). 111–116. 45 indexed citations
2.
Lokich, Jacob J., et al.. (1989). Free-Standing Cancer Centers. American Journal of Clinical Oncology. 12(5). 402–406. 3 indexed citations
3.
Byfield, John E.. (1984). Hematologie parameters in the adjustment of chemotherapy doses in combined modality treatments involving radiation. American Journal of Clinical Oncology. 7(4). 371–374. 6 indexed citations
4.
Calabro-Jones, Paula M., John E. Byfield, John F. Ward, & Thomas R. Sharp. (1982). Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro.. PubMed. 42(11). 4413–20. 103 indexed citations
5.
Floyd, Ronald A., Cecil L. Hornbeck, John E. Byfield, John C. Griffiths, & Sallie S. Frankel. (1982). Clearance of Continuously Infused 5-Fluorouracil in Adults Having Lung or Gastrointestinal Carcinoma with or without Hepatic Metastases. Drug Intelligence & Clinical Pharmacy. 16(9). 665–667. 23 indexed citations
6.
Byfield, John E., et al.. (1982). Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. International Journal of Radiation Oncology*Biology*Physics. 8(11). 1923–1933. 314 indexed citations
7.
Byfield, John E. & Paula M. Calabro-Jones. (1981). Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents. Nature. 294(5838). 281–283. 60 indexed citations
8.
Murnane, John P., John E. Byfield, John F. Ward, & Paula M. Calabro-Jones. (1980). Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents. Nature. 285(5763). 326–329. 72 indexed citations
9.
Tang, Simon G., et al.. (1980). Prognostic factors in the management of metastatic epidural spinal cord compression. International Journal of Radiation Oncology*Biology*Physics. 6(10). 1370–1370. 2 indexed citations
10.
Barone, Robert M., John E. Byfield, & Sallie S. Frankel. (1979). Combination infusional 5-fluorouracil and radiation therapy for the treatment of metastatic carcinoma of the colon to the liver. Diseases of the Colon & Rectum. 22(6). 376–382. 12 indexed citations
11.
Byfield, John E., et al.. (1977). Cellular effects of combined adriamycin and x‐irradiation in human tumor cells. International Journal of Cancer. 19(2). 194–204. 48 indexed citations
12.
Byfield, John E., et al.. (1976). Molecular interactions of the combined effects of bleomycin and x-rays on mammalian cell survival.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(3). 1138–43. 28 indexed citations
13.
Lee, Young C. & John E. Byfield. (1976). Induction of DNA Degradation In Vivo by Adriamycin 2. JNCI Journal of the National Cancer Institute. 57(1). 221–224. 48 indexed citations
14.
Lee, Young C., John E. Byfield, Leslie R. Bennett, & Paul Y. M. Chan. (1974). X-ray repair replication in L1210 leukemia cells.. PubMed. 34(10). 2624–33. 15 indexed citations
15.
Byfield, John E., et al.. (1973). Inhibition of Colony Formation by Cytotoxic Antibodies in Cervical Epidermoid Carcinoma. Radiology. 107(3). 685–686. 3 indexed citations
16.
Bennett, Leslie R., et al.. (1972). Inhibition of repair of DNA single strand breaks in mouse leukemia cells by Actinomycin D. Biochemical and Biophysical Research Communications. 49(3). 758–765. 14 indexed citations
17.
Byfield, John E. & Young C. Lee. (1970). Do Synchronizing Temperature Shifts Inhibit RNA Synthesis in Tetrahymena pyriformis?1. The Journal of Protozoology. 17(3). 445–453. 15 indexed citations
18.
Byfield, John E., et al.. (1969). A Flexible Fiber Optics Scintillation Probe for Intracavitary Dosimetry. Radiology. 92(5). 1120–1123. 1 indexed citations
19.
Byfield, John E. & Otto H. Scherbaum. (1967). Stability of division‐related protein and nucleic acid fractions in synchronized Tetrahymena. Journal of Cellular Physiology. 70(3). 265–273. 13 indexed citations
20.
Byfield, John E., S.C. Chou, & Otto H. Scherbaum. (1962). Some observations on the isolation of mitochondria from , GL. Biochemical and Biophysical Research Communications. 9(3). 226–230. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026